Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) are autoimmune diseases highly prevalent in socioeconomically disadvantaged populations. Globally, the prevalence rate for RHD is estimated at 33 million cases [1] . About 350 000 people also die from this disease annually. ARF/RHD are a sequelae of group A streptococcal (GAS) infections in which antibodies and T cells raised against the M protein of GAS react with host proteins, including those of the heart, resulting in valvular damage [2] . More than 200 different M proteins (or M-types) have been described on the surface of different GAS isolates [3] .
Group G streptococcus (GGS), a bacterium closely related to GAS, also possesses unique M proteins. Although extensive overlap in the disease spectrums of GAS and GGS has been well documented [4] [5] [6] , an association between GGS infection and ARF/RHD has never been directly established [7] [8] [9] . A serological study performed in the Australian Indigenous population was the first to suggest potential role for this organism in the initiation or exacerbation of ARF/RHD [8] . In this population, GAS is rarely recovered from the throat, which is generally considered to be a prerequisite for the development of ARF/RHD. Rather, GGS is the predominant species recovered from this niche [7] . Furthermore, it is unclear whether GGS can exacerbate GAS-induced autoimmune carditis or vice versa.
The inflammatory process in ARF has structural and functional effects on the heart that can lead to acute inflammatory damage and, ultimately, to RHD. Aschoff bodies are commonly present, containing Anitschkow cells, Aschoff cells, and T cells beneath the endocardium [10] . Further inflammation leads to fibrinous vegetations (verrucae) of the leaflets and subsequent scarring, which might ultimately lead to valvular stenosis [11] . Furthermore, prolongation of the P-R interval on electrocardiography designates features of conduction abnormality of the heart [12] .
The Lewis rat autoimmune valvulitis model [13, 14] is the only laboratory model available for investigation of pathological mechanisms of ARF/RHD. Using this model, we and others have previously demonstrated that repeated injection with whole-killed GAS or specific GAS M proteins, resulted in increased inflammation in cardiac tissue akin to those observed in patients with ARF/RHD [15, 16] .
Here we report that the histological, immunological, and functional changes observed in the cardiac tissue of rats exposed to GGS NS3396 or its M protein (Stg480) are indistinguishable to those exposed to GAS M5 or rM5 protein. Furthermore, antibody reactivity to cardiac myosin was comparable in both GGSand GAS-exposed rats, providing additional evidence that GGS may induce and/or exacerbate ARF/RHD. To our knowledge, this is the first reported experimental evidence that streptococci other than GAS can trigger ARF/RHD-like symptoms.
METHODS

Preparation of Whole-Killed GAS/GGS
GGS NS3396 was recovered from Indigenous adolescents presenting with ARF on 2 separate occasions [8] . GAS M-type-5 (T5/B/ P5 PHLS Prague), originally sourced from the Public Health Laboratory Service in London. After overnight growth on sheep blood agar (catalog no. 7266; Acumedia), single colonies of GGS NS3396 or GAS M5 were inoculated in 1000 mL of Todd Hewitt yeast (0.2%) broth (catalog no. 7161; Sigma). After overnight incubation, the cultures were centrifuged, washed, and resuspended in phosphate-buffered saline (PBS). The concentration of culture was determined by plating serially diluted aliquots of bacterial suspensions on sheep blood agar. Bacteria were killed by adding 1% formalin at 4°C for 72 hours. After washing, the final concentration was adjusted to 10 11 colony-forming units/mL.
Experimental Animals
Female Lewis rats (LEW/SsN; Albino:a,h,c:RT 1 ; n = 4-8 per group) aged 8-14 weeks were bred at James Cook University (Townsville, Australia) and randomly allocated to groups. A sample size of ≥4 per group was considered adequate to achieve statistical power, based on our previous findings [14, 16] . Rats were maintained in standard rat cages in a 12-hour light-dark cycle and commercial protein-rich pellet feed and water was supplied ad libitum. The experiments were performed with approvals from the James Cook University Animal Ethics Committee (protocol no. A2083) and the National Health and Medical Research Council's Australian Code of Practice for the Care and Use of Animals for Scientific Purposes.
Purification of Recombinant M Proteins
Recombinant M5 protein (rM5) of GAS was cloned and purified as described previously [16] . The GGS M protein gene used in this study, stg480, was cloned from NS3396 into the expression vector pJ404. Proteins were visualized using sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and concentrations were determined using the Pierce BCA Protein Assay Kit (Thermo Scientific).
Immunization of Rats
Rats were treated with either whole-killed GAS or GGS at 10 10 colony-forming units/rat or with rM5 or GGS (Stg480) at 0.5 mg/rat in 100 µL of PBS. Emulsions containing equal volumes of antigen in PBS and complete Freund's adjuvant (catalog no. F5881; Sigma) or incomplete Freund's adjuvant (catalog no. F5506; Sigma) were prepared by vortexing the suspensions for 30 minutes until a stable oil-in-water emulsion was achieved. Negative control group emulsion was prepared by mixing PBS with complete Freund's adjuvant or incomplete Freund's adjuvant. Rats were anaesthetized using a nose cone with 5% isoflurane inhalant (catalog no. 26675-46-7; LASER Animal Health) and 1-2 L/min O 2 in a gaseous anesthetic machine (AD Instrument, Power Laboratories). During interventions, 2% isoflurane was used for maintenance of anesthesia. Groups of anaesthetized rats (n = 4-8) were primarily treated subcutaneously in the hock with 200 µL of emulsion containing M protein (M5 or Stg480) or whole-killed GAS or GGS in complete Freund's adjuvant. At 1 and 3 days after the primary injection, rats were intraperitoneally administered 200 µL of PBS containing 0.3 µg of Bordetella pertussis toxin (catalog no. PHZ1174; Gibco). B. pertussis toxin is commonly used to promote the T-helper type 1 (Th1) cell response and facilitate autoimmunity in animal models [17] . Booster injections containing 0.5 mg/100 μL of M protein or 10 10 colony-forming units of whole-killed GAS/GGS were delivered in incomplete Freund's adjuvant. The complete injection schedules are shown in Table 1 . To observe the progression of the autoimmune process and inflammatory changes in hearts, rats were culled at day 35 (short term) and day 240 (long term). In all experiments, changes in rats immunized with Stg480 or GGS NS3396 were compared to those immunized with rM5 or GAS M5 and PBS. All experiments were repeated 2-4 times.
Assessment of Cytokine Levels
To detect antigen-specific T-cell cytokines, mononuclear cells were cultured as described for the proliferation assay (Supplementary Data), and supernatants were harvested after antigen stimulation for 72 hours. Quantitative measurement of interferon γ (IFN-γ; product code ab46107), interleukin 17A (IL-17A; ab119536), and interleukin 4 (IL-4; ab46073) were achieved using Abcam ELISA kits.
Echocardiography
Echocardiography was performed by an experienced researcher/ clinician blinded to the sample identity. The machine used was a Philips CX50 portable ultrasound system (Bothwell, WA) with a L15-7iO; 15 Hz-phased linear array probe with 128 elements, designed for mid-to-high frequency superficial imaging at high resolution, and the following lens footprint: elevation, 10 mm; scan plane, 32 mm, and transducer length, 89 mm. The inflammatory valves were detected as echo-dense structures and described according to number and size. The rats were scored on the basis of mitral valvular pathology (Supplementary Table 2 ). The thickness and nodular scores were added prior to analysis.
Human Study
To assess whether patients with ARF/RHD had demonstrable antibody responses to GAS/GGS M proteins or whole-killed GAS/GGS, we obtained blood samples from 8 patients at Waikato Hospital, New Zealand, between 2012 and 2015. Control blood samples were obtained from a family practice in the Waikato region. Written informed consent was obtained from all patients, and ethical approval was provided by the New Zealand Central Regional Ethics Committee (protocol no. CEN/12/06/017). Blood specimens were collected into SST tubes, and serum was separated by centrifugation. The enzymelinked immunosorbent assay (ELISA) protocol described in the Supplementary Data was followed with the exception of horseradish peroxidase-conjugated anti-human immunoglobulin G (catalog no. 2453; Santa Cruz) used at 1:3000 dilution.
Assessment of lymphocyte proliferation, antibody levels, electrocardiographic findings, and histologic findings was performed as described elsewhere [14, 16] , and details are presented in the Supplementary Data.
Statistical Analysis
Normal distribution of pooled data from the ELISA, lymphocyte proliferation assay, histologic analysis, electrocardiography, and echocardiography was established using SPSS (IBM SPSS Statistics 22) . The data from the experimental and control group that fit the Q-Q plot were compared and tested using 1-way analysis of variance with the multiple comparisons test, using GraphPad Prism 6. The nonparametric Mann-Whitney U test (2-tailed) was performed to compare data that were not normally distributed, using SPSS. The specific statistical tests used for analysis of findings from each laboratory analysis are presented in the figure legends. P values of ≤.05 were considered significant.
RESULTS
GAS M5 and GGS NS3396 and Respective M Proteins (rM5 and Group G M Protein Stg480) Cause Carditis
We and others previously demonstrated that rM5 and GAS expressing M5 induced inflammatory and other RHD-like symptoms in a rat model of valvulitis [14, 16, 18, 19] . To determine whether GGS NS3396 could invoke similar pathological and/or immune responses, rats were treated with GGS NS3396 or its M protein, Stg480, and compared to whole-killed GAS or rM5. For all groups, histological examination of heart sections demonstrated marked infiltration of mononuclear cells with variable degrees of verrucae and edema into valvular tissues. Inflammatory changes were observed both in rats, at 35 and 240 days after the primary injection of protein ( Figure 1A and Supplementary Figure 1B 
Antibodies Generated Following Exposure to GAS/GGS Antigens Recognize Host Tissue Protein
A hallmark of ARF/RHD is the presence of antibodies to M protein that cross-react with host tissue proteins [20] . Here, antibodies raised against Stg480 cross-reacted with both rM5 ( Figure 2A ) and GAS M5 ( Figure 2B ). Anti-rM5 antibodies also reacted significantly with Stg480 ( Figure 2A ) and GGS NS3396 ( Figure 2B ). Sera from rats treated with whole-killed GGS NS3396 or GAS M5 also had a similar spectrum of reactivity (Figure 2A and 2B ). Immunoglobulin G reactivity was identical when serum from protein or bacteria treated rats was evaluated in these assays. Similar to sera from rM5 and whole-killed GAS M5, sera from Stg480 and GGS NS3396 reacted significantly with cardiac myosin ( Figure 2C ). 
GAS M5-and GGS NS3396-Specific T Cells and IL-17A and IFN-γ Are
Involved in the Development of Carditis T cells play a significant role in the pathogenesis of ARF/RHD [1] . Here, splenic T cells recovered from rats treated with M protein or whole-killed GAS/GGS proliferated in the presence of rM5 and Stg480 ( Figure 3A ). Aberrant expression of inflammatory cytokines has also been associated with the development of ARF/RHD [21] . Taking into consideration that Th1/Th2/ Th17 cytokines may be involved in inflammatory responses driving ARF/RHD [22, 23] , we analyzed IFN-γ, IL-17A, and IL-4 production by splenocytes upon ex vivo restimulation with rM5 and Stg480. Significant levels of IFN-γ, IL-17A, and IL-4 (of which IL-17A levels were highest and IL-4 levels were lowest) were produced from splenocytes from rats treated Histological changes in cardiac tissues are identical following exposure to group A streptococci (GAS) and group G streptococci (GGS). A, Carditis scores were determined in Lewis rats treated with recombinant M proteins (rM5 or Stg480; n = 6) or whole-killed bacteria (GAS or GGS; n = 7-8) and compared to control rats (treated with phosphate-buffered saline [PBS]; n = 6-7). B, There was no evidence of inflammation in the mitral valves and myocardium observed in control rats (score 0). C, Inflammatory focal lesions, verrucae, and edematous mitral valve in rats treated with M protein or whole-killed GAS and GGS. D, Rats treated with M protein or bacteria had interstitial focal myocarditis with granulomatous structure (arrow). x, Aschoff-like cells; y, Anitschow-like cells; z, polymorph. *P < .0001, by 1-way analysis of variance.
with M protein and those treated with whole-killed GAS/GGS (Figure 3B-D) . The elevated IL-17A and IFN-γ levels show the importance of both cytokines in the rat model of RHD. IL-17A has been shown elevated in ARF sera in a Turkish study [24] and is linked to the development of fibrosis [25] . IL-17A is also distinctly linked with group A streptococcal infections [26] , and now our evidence above also indicates that GGS and GAS are significant inducers potentially of the Th17/IL-17A signature.
Electrocardiographic and Echocardiographic Changes are Identical Following Exposure to GAS/GGS Antigens
Prolongation of the P-R interval on electrocardiography reflects conduction abnormalities of the myocardium [27] . In this study, prolonged P-R intervals were recorded in rats treated with M protein ( Figure 4A ) and whole-killed GAS/GGS ( Figure 4B ), compared with findings for the control. Using echocardiography, we also found uniform valvular structures in the control rats ( Figure 4C ). In contrast, valvular fibrosis with nodules was observed in the rats treated with whole-killed GAS M5 or GGS NS3396 ( Figure 4C and Figure 4D ). The echocardiographic changes observed in GGS NS3396-treated rats were indistinguishable from those treated with GAS M5 (Supplementary Figure 5) .
GAS and GGS Have a Synergistic Effect in the Development of Autoimmune Carditis
To test the hypothesis that GGS exacerbates GAS-induced ARF/RHD or vice versa, rats were primed with rM5 and subsequently boosted with Stg480. Alternatively, Stg480-primed rats Antibodies generated following exposure to group A streptococci (GAS) and group G streptococci (GGS) react significantly with both organisms, rM proteins, and cardiac myosin. A, Immunoglobulin G (IgG) antibody in the sera from rats treated with rM5 (n = 6) and Stg480 (n = 6) reacted with rM5 and Stg480 (left). IgG reactivity to rM5 and Stg480 was identical in serum from whole-killed GAS (n = 7) or GGS NS3396 (n = 8)-treated rats (right). B, IgG response to whole-killed GAS and GGS in rats treated with rM5 and Stg480 (left) and whole-killed GAS/GGS (right). C, Antisera raised in rats treated with rM5 and Stg480 (left) and whole-killed GAS or GGS (right) reacted significantly against cardiac myosin at a 1:100 dilution. In all experiments, phosphate-buffered saline (PBS)-treated control rats were included (n = 6-7). Error bars represent standard errors of the means. *P < .05, **P < .01, and ***P < .001, by 1-way analysis of variance with the multiple comparison test (A and B) and the Mann-Whitney U test (C).
were boosted with rM5. Regardless of the prime/boost antigen combination, prolonged P-R intervals ( Figure 5A ) and histological changes ( Figure 5A and Supplementary Figure 6 T cells from group A streptococci (GAS) and group G streptococci (GGS) treated rats proliferate in response to streptococcal antigens and produce the cytokine interleukin 17A (IL-17A), interferon γ (IFN-γ ), and interleukin 4 (IL-4), with levels of IL-17A highest and levels of IL-4 lowest. A, Splenic T-cell proliferative response in rats treated with rM5 or Stg480 (n = 6; left) and whole-killed GAS (n = 7) or GGS (n = 8; right) to rM5 and Stg480 is expressed as stimulation index. B, Splenic cells from rats treated with rM5 or Stg480 (left) and whole-killed GAS or GGS (right) produced a significantly high amount of interferon γ (IFN-γ) in response to rM5 and Stg480. IL-17A and IL-4 produced by splenocytes from rats treated with rM5 or Stg480 (C and D, left) and whole-killed GAS or GGS (C and D, right) and stimulated with rM5 and Stg480 were significantly higher as compared to control rats. Phosphate-buffered saline (PBS)-treated control rats were included (n = 6-7) in all experiments. Error bars represent standard errors of the mean. *P < .05, **P < .01, ***P < .001, and ****P < .0001, by 1-way analysis of variance with the multiple comparison text.
Antibodies from ARF/RHD Recognize Both GAS and GGS Antigens
Our in vitro results demonstrate that treatment with Stg480 or GGS NS3396 resulted in elaboration of responses that might be associated with ARF/RHD in humans. To study ARF/RHD sera to determine whether antibodies that cross-react with Stg480 were present in sera from patients with ARF/RHD, ELISA was conducted, using the sera collected from 8 patients presenting with a first episode of ARF. Elevated immunoglobulin G responses to Stg480 were observed in all patients, with ODs similar to that observed when rM5 was the capture antigen ( Figure 6 ). High immunoglobulin G reactivity was also observed in ARF/RHD sera when whole GAS serotype M5 or GGS NS3396 was the antigen.
GAS/GGS M Proteins Have High Amino Acid Identity Within the C-Repeat Region
M proteins from GAS and GGS have both high sequence and structural homology [5, 6] . Additionally, these organisms may exchange M protein genes via recombination [7, 28] . To identify whether regions of similarity in the 2 M proteins used in this study may account for the observed responses in rats, a pairwise NEEDLE alignment [29] was performed. The N-terminal region, A-repeats, and B-repeats of these 2 proteins were all found to have limited primary amino acid identity (21%). However, the C-repeat region had a high level of amino acid identity (80%; data not shown).
DISCUSSION
Classically, throat infection by GAS has been considered a prerequisite for the development of ARF/RHD. However, in ARF/ RHD-endemic areas, pharyngeal carriage of GAS in these populations is relatively low, and GGS can be recovered from this niche more frequently [8, 9, 30] . On the basis of these epidemiological observations, it has been postulated that GAS throat Electrocardiographic and echocardiographic changes demonstrate functional impairment following exposure to group A streptococci (GAS) and group G streptococci (GGS). A, Prolongation of P-R interval in rM5-and Stg480-treated rats (n = 6) was observed following 35 days of priming injection. B, Similar findings were recorded in whole-killed GAS/GGS treated rats (n = 7-8) following 240 days of priming injection. C, Impairment of cardiac function was further demonstrated by echocardiography. Scores were generated based on the mitral valvular thickening and the presence of nodules. The mitral valve of phosphate-buffered saline (PBS)-treated animals had normal movement with uniform valvular structure (score 0, top; n = 7). Pathological changes were observed with fibrotic thickening of the valve leaflet with/without nodules (score 2, bottom). D, Higher scores on echocardiography were observed in the whole-killed GAS-or GGS-treated rats (n = 7-8) as compared to PBS-treated controls (n = 7). Statistical difference. Error bars represent standard errors of the means. LA, left atrium; LV, left ventricle; MV, mitral valves; RA, right atrium; RV, right ventricle. *P < .001 and **P < .0001, by the Mann-Whitney U test (A) and 1-way ANOVA (B and D).
infection may not necessarily be the only trigger for the disease sequelae [9, 31] . Here, we are the first to provide in vitro evidence that the immunization of rats with either a GGS M protein or a strain of GGS circumstantially associated with ARF/ RHD induce valvulitis and cardiac inflammation similar to GAS and GAS M protein. The changes observed in this model (prolonged P-R intervals, cardiac inflammation, presence of Aschoff nodules, cytokine production, and antibody and T-cell responses) when Stg480 or GGS were used as the injected antigen are all consistent with features of ARF/RHD in humans.
Our model of RHD valvulitis provided new evidence for the IL-17A/IFN-γ signature and suggests that this may be an important pathway in RHD. Our data suggest that both GAS and GGS and their M proteins are responsible for induction of high levels of IL-17A and IFN-γ, as well. Th17 cells and IL-17A were discovered only a decade ago [32] but have been found to have a very important response in extracellular bacterial infections and immune responses in autoimmune diseases where fibrosis is a thematic end point [24] . The study of Th17 cells and IL-17A was reported in GAS infections in mice [26, 33] . IL-17A Figure 5 . Exposure to group A streptococci (GAS) and group G streptococci (GGS) has a synergistic effect that leads to the development of interleukin 17A (IL-17A)/interferon γ (IFN-γ)-mediated carditis. To determine synergistic effect of GAS and GGS in the development of rheumatic heart disease (RHD), rM5 protein-treated rats (n = 5) were boosted thrice at weekly intervals with Stg480 protein and vice versa (n = 4). A, Prolongation of P-R intervals revealed by electrocardiography and higher carditis scores were observed in the rats. B, A significantly higher T-cell proliferative response was observed. C, Higher serum IgG titer against rM5 and Stg480, whole-killed (WK) GAS and GGS, and cardiac myosin was also demonstrated. D, There was higher amount of IFN-γ, IL-17A, and IL-4 produced by splenic T cells in response to rM5 and Stg480. Error bars represent standard errors of means. *P < .05, **P < .01, and ***P < .0001, by the Mann-Whitney U test (carditis, T-cell proliferation, IL-17A, and IL-4) and 1-way analysis of variance (P-R intervals and IFN-γ).
has been reported in ARF/RHD sera in Turkey [24] . Although there is some previous evidence for the IL-17A signature, no studies have shown it in the Lewis rat model of RHD or in GGS exposure in animal models. In ARF/RHD, there is strong evidence of the recognition of heart proteins by autoreactive T cells via molecular mimicry [1, [34] [35] [36] . In this study, splenic T cells from rats treated with M protein or whole-killed GAS/GGS proliferated in the presence of M protein of both GAS and GGS. This was similar to the responses previously observed with M protein of GAS and peptides [15, 16, 37, 38] . In addition, high levels of M protein-specific IFN-γ and IL-17A in this study suggested that a Th1/Th17-dominated immune response may drive heart pathology. Heart-infiltrating T cells isolated from the heart valves of patients with ARF/RHD have previously been shown to be predominantly IFN-γ producing. IL-4-producing T cells, however, were demonstrated in the myocardium [21, 22, 36, 39] , but IL-4 was not a dominant cytokine in the rat model, although it was seen at low concentrations. IL-17 is important in recruiting neutrophils and macrophages to the site of infection [40, 41] and is a relatively new finding in the development of autoimmune carditis in our study herein. In another study, high concentrations of IL-17 in the serum of Lewis rats and high expression of IL-17 in the mitral valves of rats and patients were observed [23] . Our findings suggest that the altered balance between Th1/Th2/Th17 cytokines may drive pathology in ARF/RHD irrespective of whether the disease process is triggered by GAS or GGS infection.
Inflammation of the heart with mitral valvular fibrosis is a hallmark of patients with ARF/RHD [10] . In this study, Lewis rats treated with Stg480, a M protein only found in specific GGS or whole-killed GGS NS3396, showed evidence of carditis similar to the results gained when rM5 or GAS M5, a GAS strain associated with ARF/RHD, were used in the same experiments [15, 16, 18, 19, 42, 43] . The Lewis rat was chosen as a model as it is highly susceptible to developing autoimmune carditis [13] . In patients with ARF/RHD, Aschoff nodules composed of Anitschkow cells and Aschoff cells have been described in cardiac tissue [44] . All rats treated with either protein or bacteria in this study developed myocarditis with granulomatous structures giving an Aschoff nodule-like appearance. Macrophages similar to Anitschkow cells and necrotic cells similar to Aschoff cells were also observed in both myocardial and valvular tissues. Similar lesions were observed by Quinn et al [42] in GAS rM6-treated rats and by Lymbury et al [15] in the rats treated with pooled conserved-region peptides of GAS M5. In addition, Kirvan et al [43] identified cardiopathogenic epitopes of M5 protein in the Lewis rat and passively transferred valvulitis with T-cell lines.
Molecular mimicry between streptococcal antigens and host tissue proteins is considered to play a role in ARF/RHD pathogenesis [1, 35] . In this regard, the GAS M protein shares structural homology with α-helical coiled-coil host proteins, such as cardiac myosin [1, 35, 45, 46] . Stg480 is predicted to have a similar α-helical coiled-coil structure. Within the rM5 protein, we have also shown that specific peptides from the B-repeat region of the M protein induce inflammatory responses in the Lewis rat valvulitis model used here [16] . Identity between these known cardiopathogenic peptides and Stg480 was found in corresponding regions of Stg480, demonstrating <35% identity. However, within Stg480, the cardiopathogenic peptides from B-and C-repeat regions, which have the autoimmune capability to induce carditis, are yet to be determined.
In ARF/RHD, antibody cross-reactivity between GAS M proteins with cardiac myosin has been well documented [38, 47] . In this study, serum from rats treated with Stg480 or NS3396 reacted with cardiac myosin. Previously, in murine experiments, it was observed that antibodies raised against cardiac myosin had greater reactivity to GGS than GAS M proteins [8] . Sera from patients with a first episode of ARF also responded to M proteins and whole-killed GAS/GGS ( Figure 6 ). Our data provide further circumstantial evidence for a potential role of GGS in the autoimmune pathology of ARF/RHD.
Electrocardiographic and echocardiographic changes aid in the clinical diagnosis and monitoring of patients with ARF/RHD [1] . In this study, prolongation of the P-R interval observed in the rats treated with M protein or wholekilled GAS/GGS. Similar findings were observed in the rats repeatedly exposed to GAS rM5 protein [14] . Impaired cardiac function or valvular leaflet movement have not been previously assessed using echocardiography in the Lewis . Human acute rheumatic fever (ARF) serum immunoglobulin G (IgG) reacts with both group A streptococci (GAS) and group G streptococci (GGS) antigens. Sera from 8 patients in whom the first episode ARF was diagnosed were screened for IgG reactivity against Stg480 and rM5 and whole-killed (WK) extracts of GGS and GAS by enzyme-linked immunosorbent assay (ELISA). The line on the bars represents the cutoff for each antigen in the ELISA (mean ± 3 SDs for negative sera). All patients with ARF demonstrated positive reactivity against each of the antigens. There was no significant difference in the mean IgG levels for Stg480 and rM5 in sera from patients with ARF (mean absorbance [±SD] at serum dilution of 1:1000, 1.00 ± 0.19 and 0.96 ± 0.27, respectively). Similarly, there was no significant difference in the mean IgG levels for WK extracts from GGS and GAS in sera from patients with ARF (mean absorbance [±SD] at serum dilution of 1:100, 0.64 ± 0.17 and 0.63 ± 0.18, respectively). Error bars represent SDs.
rat autoimmune valvulitis model. Here, we are the first to demonstrate that Lewis rats treated with Rm proteins or whole-killed GAS/GGS had fibrotic and/or nodular mitral valves that may have been promoted by the elevated IL-17A/ IFN-γ signatures. It has been reported that T cells that are producing both IL-17 and IFN-γ are the most potent in producing autoimmune diseases [48] . It is considered that multiple separate infections with GAS may be required for development of ARF/RHD in some instances [2, 20] . There is no evidence that streptococcal strains causing these infections need to be of the same M type. Our results suggest that GGS may also contribute in our rat model of valvular heart disease. This is particularly relevant in global regions where ARF/RHD is endemic and GAS is rarely recovered from the throat. For primary prophylaxis of ARF/RHD, only GAS-positive individuals are provided with antibiotic therapy [49] . Therefore, the lack of awareness that GGS could trigger ARF/RHD may result in undertreatment of pharyngeal and/or skin infections, increasing the likelihood of ARF/RHD in areas of endemicity. Further studies should be done to identify the disease-associated common epitopes among GAS/GGS isolates, not only to develop a more precise serological assay to detect a preceding GAS/GGS infection, but to inform development of vaccines to prevent streptococcal infections. Our experimental observations suggest that repetitive infections with GAS and/or GGS have the potential to lead to ARF/RHD. Therefore, ARF/RHD should no longer be described in the scientific literature as a disease solely triggered by GAS.
Notes
